Find MIV-818 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Miv818, Miv-818, Unii-q1i6yz0ngf, Q1i6yz0ngf, Troxacitabine nucleotide prodrug miv-818, 1-((2s,4s)-2-((((s)-(4-bromophenoxy)(((s)-1-oxo-1-(((s)-pentan-2-yl)oxy)propan-2-yl)amino)phosphoryl)oxy)methyl)-1,3-dioxolan-4-yl)-2-oxo-1,2-dihydropyrimidin-4-amine
Molecular Formula
C22H30BrN4O8P
Molecular Weight
589.4  g/mol
InChI Key
JBYKMODFCUCTGY-LLSQRQBFSA-N
FDA UNII
Q1I6YZ0NGF

MIV-818
Fostroxacitabine Bralpamide is a liver-targeting nucleotide phosphoramidate prodrug of troxacitabine monophosphate (TRX-MP), a dioxolane derivative and L-configuration deoxycytidine analogue, with potential antineoplastic activity. Upon oral administration, fostroxacitabine bralpamide is rapidly and specifically hydrolyzed in hepatocytes by liver carboxylesterase 1 (carboxylesterase 1, CE-1), generating high levels of the chain-terminating nucleotide, troxacitabine triphosphate (TRX-TP) in the liver. TRX-TP is then incorporated into tumor cell DNA, leading to termination of DNA synthesis and inhibition of tumor cell proliferation.
1 2D Structure

MIV-818

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2S)-pentan-2-yl] (2S)-2-[[[(2S,4S)-4-(4-amino-2-oxopyrimidin-1-yl)-1,3-dioxolan-2-yl]methoxy-(4-bromophenoxy)phosphoryl]amino]propanoate
2.1.2 InChI
InChI=1S/C22H30BrN4O8P/c1-4-5-14(2)33-21(28)15(3)26-36(30,35-17-8-6-16(23)7-9-17)32-13-20-31-12-19(34-20)27-11-10-18(24)25-22(27)29/h6-11,14-15,19-20H,4-5,12-13H2,1-3H3,(H,26,30)(H2,24,25,29)/t14-,15-,19-,20-,36-/m0/s1
2.1.3 InChI Key
JBYKMODFCUCTGY-LLSQRQBFSA-N
2.1.4 Canonical SMILES
CCCC(C)OC(=O)C(C)NP(=O)(OCC1OCC(O1)N2C=CC(=NC2=O)N)OC3=CC=C(C=C3)Br
2.1.5 Isomeric SMILES
CCC[C@H](C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1OC[C@H](O1)N2C=CC(=NC2=O)N)OC3=CC=C(C=C3)Br
2.2 Other Identifiers
2.2.1 UNII
Q1I6YZ0NGF
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Miv818

2. Miv-818

3. Unii-q1i6yz0ngf

4. Q1i6yz0ngf

5. Troxacitabine Nucleotide Prodrug Miv-818

6. 1-((2s,4s)-2-((((s)-(4-bromophenoxy)(((s)-1-oxo-1-(((s)-pentan-2-yl)oxy)propan-2-yl)amino)phosphoryl)oxy)methyl)-1,3-dioxolan-4-yl)-2-oxo-1,2-dihydropyrimidin-4-amine

7. 2129993-56-0

8. L-alanine, N-((((2s,4s)-4-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1,3-dioxolan-2-yl)methoxy)(4-bromophenoxy)phosphinyl)-, (1s)-1-methylbutyl Ester

9. Chembl4594349

10. Fostroxacitabine Bralpamide [usan]

11. Who 11760

12. Fostroxacitabine Bralpamide [inn]

13. [(2s)-pentan-2-yl] (2s)-2-[[[(2s,4s)-4-(4-amino-2-oxopyrimidin-1-yl)-1,3-dioxolan-2-yl]methoxy-(4-bromophenoxy)phosphoryl]amino]propanoate

14. 1884205-97-3

2.4 Create Date
2019-12-06
3 Chemical and Physical Properties
Molecular Weight 589.4 g/mol
Molecular Formula C22H30BrN4O8P
XLogP32.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count13
Exact Mass588.09846 g/mol
Monoisotopic Mass588.09846 g/mol
Topological Polar Surface Area151 Ų
Heavy Atom Count36
Formal Charge0
Complexity882
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

MIV-818 Manufacturers

A MIV-818 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MIV-818, including repackagers and relabelers. The FDA regulates MIV-818 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MIV-818 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

MIV-818 Suppliers

A MIV-818 supplier is an individual or a company that provides MIV-818 active pharmaceutical ingredient (API) or MIV-818 finished formulations upon request. The MIV-818 suppliers may include MIV-818 API manufacturers, exporters, distributors and traders.

MIV-818 GMP

MIV-818 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MIV-818 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MIV-818 GMP manufacturer or MIV-818 GMP API supplier for your needs.

MIV-818 CoA

A MIV-818 CoA (Certificate of Analysis) is a formal document that attests to MIV-818's compliance with MIV-818 specifications and serves as a tool for batch-level quality control.

MIV-818 CoA mostly includes findings from lab analyses of a specific batch. For each MIV-818 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MIV-818 may be tested according to a variety of international standards, such as European Pharmacopoeia (MIV-818 EP), MIV-818 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MIV-818 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty